<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Res Med Sci</journal-id><journal-id journal-id-type="iso-abbrev">J Res Med Sci</journal-id><journal-id journal-id-type="publisher-id">JRMS</journal-id><journal-title-group><journal-title>Journal of Research in Medical Sciences : The Official Journal of Isfahan University of Medical Sciences</journal-title></journal-title-group><issn pub-type="ppub">1735-1995</issn><issn pub-type="epub">1735-7136</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">22973320</article-id><article-id pub-id-type="pmc">3430016</article-id><article-id pub-id-type="publisher-id">JRMS-16-1273</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Relation of resistin levels with C-reactve protein, homocysteine and uric acid in smokers and non-smokers</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Esbah</surname><given-names>Onur</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>G&#x000fc;rsoy</surname><given-names>G&#x000fc;l</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Kirnap</surname><given-names>Nazli Gulsoy</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Cetiner</surname><given-names>Hacer</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Demirba&#x0015f;</surname><given-names>Berrin</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Acar</surname><given-names>Yasar</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Bayram</surname><given-names>Murat</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1"><label>1-</label>Department of Internal Medicine, Ministry of Health Ankara Education and Research Hospital, Ankara, Turkey</aff><aff id="aff2"><label>2-</label>Associate Professor, Department of Internal Medicine, Ministry of Health Ankara Education and Research Hospital, Ankara, Turkey</aff><aff id="aff3"><label>3-</label>Associate Professor, Departement of Endocrinology, MESA Hospital, Ankara, Turkey</aff><author-notes><corresp id="cor1">
Corresponding Author: G&#x000fc;l G&#x000fc;rsoy, E-mail: <email xlink:href="gulgursoyyener@yahoo.com">gulgursoyyener@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>10</month><year>2011</year></pub-date><volume>16</volume><issue>10</issue><fpage>1273</fpage><lpage>1279</lpage><history><date date-type="received"><day>05</day><month>4</month><year>2011</year></date><date date-type="accepted"><day>29</day><month>9</month><year>2011</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; Journal of Research in Medical Sciences</copyright-statement><copyright-year>2011</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>BACKGROUND:</title><p>The association between C-reactive protein, homocysteine, uric acid levels and cardiovascular risk have been debated for decades. Resistin is a newly discovered adipocyte derived cytokine. Smoking besides its effect on atherosclerosis, is shown to alter adipocytokine levels. Bearing in mind, these complex relationship of resistin with smoking, C-reactive protein, homocysteine and uric acid, we planned to investigate the association of resistin and these cardiovascular risk factors in smoker and non-smoker subjects.</p></sec><sec id="st2"><title>METHODS:</title><p>We conducted a cross-sectional randomized study including 52 smoking and 33 non-smoking men. After making comparisons of C-reactive protein, homocysteine, uric acid and resistin between the two groups, we classified the subjects according to their insulin resistance and body mass and made again the comparisons..</p></sec><sec id="st3"><title>RESULTS:</title><p>Resistin levels were higher in smokers than in non-smokers (p&#x0003c;0.001) and also in insulin resistant than in non-insulin resistant smokers (p&#x0003c;0.05). Resistin levels were indifferent in non-smokers as insulin resistance was concerned and in smoker or non-smokers as body mass index was concerned. As all subjects were grouped based on homeostasis model assesment index and body mass index, neither C-reactive protein nor homocysteine and uric acid levels differred.</p></sec><sec id="st4"><title>CONCLUSIONS:</title><p>We found that smoking may have influence on resistin levels and in smokers, insulin resistance is related to resistin levels, but in smoker and non-smokers body mass may not have any association with resistin. Resistin also may not have a role in C-reactive protein, homocysteine and uric acid levels both in smokers and non-smokers.</p></sec></abstract><kwd-group><title>KEYWORDS</title><kwd>CRP</kwd><kwd>Homocysteine</kwd><kwd>Uric Acid</kwd><kwd>Resistin</kwd><kwd>Smoking</kwd></kwd-group></article-meta></front><body><p>Atherosclerosis is an inflammatory disease which is initiated in early childhood in the vascular intima.<xref ref-type="bibr" rid="ref1">1</xref> It has been accepted that atherosclerosis has traditional risk factors, such as age, family history, ethnicity, gender, smoking, hyper-tension, hyperlipidemia, diabetes, obesity, sedantery life and mental stress. Nowadays, new risk factors are considered such as, C-reactive protein (CRP), homocysteine and uric acid.</p><p>CRP is a sensitive marker of inflammation.<xref ref-type="bibr" rid="ref2">2</xref> Although it is unknown whether CRP is involved in coronary heart disease patho-genesis,<xref ref-type="bibr" rid="ref3">3</xref><xref ref-type="bibr" rid="ref4">4</xref> elevated serum CRP levels are associated with cardiovascular risk factors and obesity.<xref ref-type="bibr" rid="ref5">5</xref><xref ref-type="bibr" rid="ref6">6</xref> Eversince McCully was the first to draw attention to the relationship between homocysteine and atherosclerosis in 1967, plasma homocysteine levels were widely accepted as an independent risk factor in cardiovascular disease.<xref ref-type="bibr" rid="ref7">7</xref><xref ref-type="bibr" rid="ref8">8</xref> Likewise, the association between increased serum uric acid levels and cardiovascular risk have been debated for decades and studies have provided conflicting results regarding the clinical significance of serum uric acid levels in cardiovascular events.<xref ref-type="bibr" rid="ref9">9</xref>&#x02013;<xref ref-type="bibr" rid="ref11">11</xref></p><p>It is shown that smoking alters adipo-cytokine levels which are associated with insulin resistance, type 2 diabetes, athero-sclerosis and cardiovascular disease.<xref ref-type="bibr" rid="ref12">12</xref>&#x02013;<xref ref-type="bibr" rid="ref16">16</xref> Adipocytokines play a significant role in pathogenesis of low grade inflammation associated with type 2 diabetes, obesity, metabolic syndrome, insulin resistance and in chronic inflammatory and autoimmune diseases.<xref ref-type="bibr" rid="ref17">17</xref>&#x02013;<xref ref-type="bibr" rid="ref20">20</xref> Resistin is a recently found adipocytokine.<xref ref-type="bibr" rid="ref17">17</xref><xref ref-type="bibr" rid="ref21">21</xref>&#x02013;<xref ref-type="bibr" rid="ref23">23</xref> The subject of its role in insulin resistance, obesity and type 2 diabetes mellitus (T2DM) in human is conflicting.<xref ref-type="bibr" rid="ref24">24</xref>&#x02013;<xref ref-type="bibr" rid="ref30">30</xref></p><p>Keeping in mind these complex associations among CRP, homocysteine, uric acid, atherosclerosis, obesity, insulin resis-tance and resistin, we planned to seek the relation between resistin levels and CRP, homocysteine, uric acid after controlling smoking behavior and insulin resistance and body mass index.</p><sec sec-type="methods" id="sec1-1"><title>Methods</title><sec id="sec2-1"><title/><sec id="sec3-1"><title>Subjects</title><p>A total of 52 male smokers aged 25-45 years (36.8&#x000b1;6.8), were recruited from the outpatient Clinic of Ankara Education and Research Hospital from January 2009 to May 2009. 33 aged matched (36.7 &#x000b1; 7.2) male subjects formed the control group. This was a cross-sectional study, and subjects were selected randomly. As resistin serum and mRNA levels were significantly higher in females than in males at all ages, in order to obtain an homogenous group we examined only males. Smokers have been smoking at least for 2 years and at least ten cigarettes daily.</p><p>Subjects with female gender, hypertension, diabetes mellitus, glucose intolerance, hyperlipidemia, conditions which may affect metabolic parameters (such as tyroid dys-functions in past history or nowadays), chronic diseases, infection and coronary artery disease were excluded.</p><p>After detailed physical examination, in all subjects body weight and height were measured. Body mass index (BMI) was calculated as weight in kilograms divided by the square of height in meters. Blood was withdrawn after 12 h of overnight fasting, at 08.30 a.m. for CRP, homocysteine, uric acid and resistin levels.</p><p>This study was performed according to the Helsinki decleration 2008. The local ethics committee approved this study and all the subjects gave written informed consent.</p></sec><sec id="sec3-2"><title>Methods</title><p>An indirect measure of insulin resistance was calculated from the fasting plasma insulin (munite/ml) &#x000d7; fasting plasma glucose (mmol/l)/22.5 formula as homeostasis model assessment of insulin resistance (HOMA-IR). As in normal person HOMA-IR level was stated to be &#x0003c; 2.7, it was chosen a cut-point for insulin resistance.<xref ref-type="bibr" rid="ref31">31</xref></p><p>High sensitivity C-reactive protein (CRP) was measured by immunnoflowmetric tests by Beckman-Cutler device. Homocysteine concentrations were determined according to the method of HPLC using Agilend 1100 device. Uric acid was measured by calorimetric methods.</p><p>For the measurements of resistin, after fasting blood samples were drawn, they were put into a dry tube, and were santrifuged, 5000 cycle/min in 10 minutes. Serum was then seperated and placed in another dry tube before storing at -80&#x000b0;C. Serum resistin levels were evaluated by a commercial resistin ELISA kit.</p></sec><sec id="sec3-3"><title>Statistical analysis</title><p>Calculations were performed using SPSS version 11.5 (Customer ID 30000105 930). Data were presented as mean &#x000b1; SD. Student t-test was used to compare the groups in a parametric way. A p value of &#x0003c; 0.05 was considered as statistically significant. Pearson correlation coofficient was used for the correlation analysis.</p></sec></sec></sec><sec sec-type="results" id="sec1-2"><title>Results</title><p>In smoker group, resistin levels were statistically found higher than in non-smoker group (p&#x0003c;0.001). There were no difference in CRP, homocysteine and uric acid levels between the two groups (<xref ref-type="table" rid="T1">Table 1</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Results of tests in smoker and non-smoker groups</p></caption><graphic xlink:href="JRMS-16-1273-g001"/></table-wrap><p>As smoker group was grouped according to their HOMA-IR levels, subjects with HOMA-IR&#x0003c;2.7 had lower resistin levels than subjects with HOMA-IR &#x02265; 2.7 (p &#x0003c; 0.05). CRP, homocysteine and uric acid levels were not different (<xref ref-type="table" rid="T2">Table 2</xref>). When non-smoker group was grouped as HOMA-IR, subjects with HOMA-IR&#x0003c;2.7 and HOMA-IR&#x02265;2.7 did not show any statistically different parameters (<xref ref-type="table" rid="T2">Table 2</xref>).</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Characteristics of smoker and non-smoker group whose Homeostasis model assessment-Insulin resistance index was &#x0003c;2.7 vs. HOMA-IR&#x02265;2.7.</p></caption><graphic xlink:href="JRMS-16-1273-g002"/></table-wrap><p>If smoker group was classified based on their BMI, neither CRP, homocysteine and uric acid nor resistin levels were found statistically different between the subgroups (<xref ref-type="table" rid="T3">Table 3</xref>). In non-smoker group no difference in any parameter was found when BMI was used to divide it into subgroups. (<xref ref-type="table" rid="T3">Table 3</xref>).</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Characteristics of smoker and non-smoker groups when body mass index was &#x0003c; 27 vs. BMI&#x02265;27.</p></caption><graphic xlink:href="JRMS-16-1273-g003"/></table-wrap><p>When we made the correlation analysis of smoker and non-smoker group, we did not find any positive or negative correlations between CRP, homocysteine, uric acid and resistin.</p></sec><sec sec-type="discussion" id="sec1-3"><title>Discussion</title><p>We planned to find out if the interesting adipocytokine, resistin is associated with newly accepted atherosclerotic markers such as CRP, homocysteine and uric acid in subjects who smoke or do not. We found that in smokers with insulin resistance serum resistin levels were high, but between the two groups who smoked or did not smoke, who had insulin resistance or did not have, and who were obese or were not obese, CRP, homocysteine and uric acid levels were not different.</p><p>Cardiovascular disease accounts for nearly 40% of all deaths each year.<xref ref-type="bibr" rid="ref6">6</xref> The factors that make up the Framingaham risk score (age, sex, blood pressure, serum total or low density lipoprotein cholesterol level, high density lipoprotein cholesterol level, smoking and diabetes) account for most of the excess risk for incident coronary heart disease.<xref ref-type="bibr" rid="ref32">32</xref> However, these factors do not explain all of the excess risk,<xref ref-type="bibr" rid="ref33">33</xref> , so some markers have received attention as new or emerging risk factors that could account for some of the unexplained variability in cardiovascular heart disease, such as CRP, homocysteine or uric acid.</p><p>CRP, a pentameric protein produced by the liver, has emerged as the golden marker for inflammation. When measured in blood, CRP proved to be a strong and independent predictor of cardiovascular disease even in healthy asymptomatic subjects.<xref ref-type="bibr" rid="ref33">33</xref>&#x02013;<xref ref-type="bibr" rid="ref34">34</xref> A direct comparison of CRP and low density lipoprotein cholesterol (LDL-C) showed that CRP is a more valuable predictor for cardiovascular events and death, compared to LDL-C.<xref ref-type="bibr" rid="ref35">35</xref></p><p>Although the casual relationship between hyperhomocysteinemia and cardiovascular mortality and morbidity is not so clear, consistent findings from a large number of studies strongly support an association between homocysteine level and cardiovascular events.<xref ref-type="bibr" rid="ref7">7</xref><xref ref-type="bibr" rid="ref8">8</xref> However, in some studies a positive correlation between plasma homocysteine levels and severity of coronary lesions was also determined.<xref ref-type="bibr" rid="ref36">36</xref><xref ref-type="bibr" rid="ref37">37</xref>.</p><p>Uric acid is a novel cardiovascular risk factor, but its use as an independent risk factor for so-called disease still remains controversial.<xref ref-type="bibr" rid="ref9">9</xref>&#x02013;<xref ref-type="bibr" rid="ref11">11</xref> In concordance with the studies claiming that increased uric acid levels were associated with an increase in coronary heart disease risk, use of allopurinol has been shown to be related with reduced mortality risk and with reduced blood pressure in some trials.<xref ref-type="bibr" rid="ref38">38</xref><xref ref-type="bibr" rid="ref39">39</xref>.</p><p>Smoking is well established as a casual factor in coronary heart disease and stroke. Furthermore, large studies suggested that smoking is associated with the development of type 2 diabetes in men and women consistent with evidence linking smoking and insulin resistance.<xref ref-type="bibr" rid="ref12">12</xref>&#x02013;<xref ref-type="bibr" rid="ref16">16</xref> Smoking subjects with impaired glucose tolerance and diabetes appeared more insulin resistant than their non-smoking counterparts.<xref ref-type="bibr" rid="ref12">12</xref><xref ref-type="bibr" rid="ref40">40</xref> Smoking also alters levels of adipocytokines.<xref ref-type="bibr" rid="ref16">16</xref><xref ref-type="bibr" rid="ref41">41</xref><xref ref-type="bibr" rid="ref42">42</xref></p><p>Adipocyte related resistin is a circulating protein implicated in insulin resistance in rodents, but the role of human resistin is uncertain because it is produced also by macrophages.<xref ref-type="bibr" rid="ref24">24</xref>&#x02013;<xref ref-type="bibr" rid="ref30">30</xref> Besides its role in inflammation,<xref ref-type="bibr" rid="ref43">43</xref>&#x02013;<xref ref-type="bibr" rid="ref45">45</xref> some papers reported that in humans, plasma resistin levels correlate with obesity, insulin resistance and type 2 diabetes, while other authors failed to observe any correlation of plasma resistin levels with metabolic or anthropometric parameters. Different explanations could account for these discrepancies including the use of different assay methods, low number of patients enrolled in the different studies and the definition used to select patients. Bearing in mind the relationship of atherosclerosis with inflammation, a number of studies investigated the association of resistin with inflammatory markers such as CRP<xref ref-type="bibr" rid="ref44">44</xref>&#x02013;<xref ref-type="bibr" rid="ref46">46</xref> and also resistin was found to be related to coronary artery calcification.<xref ref-type="bibr" rid="ref47">47</xref>&#x02013;<xref ref-type="bibr" rid="ref49">49</xref></p><p>The results of current study may have several important implications. First, our findings confirm that smoking elevates the levels of resistin. Second, in smokers resistin levels are associated with insulin resistance, but in non-smokers resistin does not differ when insulin resistance is present or absent. Third, in smoker or in non-smoker subjects if obesity exists or not, resistin levels are not significantly different. Fourth, disputatious atherosclerotic markers such as CRP, homocysteine or uric acid are not statistically high in smokers than in non-smoker counterparts. Also, in smoker subjects, insulin resistance or obesity did not alter the levels of these markers. In non-smokers, the result is the same. Fifth, CRP, homocysteine or uric acid are not correlated with serum resistin concentrations neither in smokers nor in non-smokers.</p><p>Smoking is associated with increased plasma homocysteine levels, and both are associated with an increased risk of cardiovascular disease.<xref ref-type="bibr" rid="ref50">50</xref> It was also determined that passive smoke exposure in never-smokers is positively and independently associated with plasma homocysteine levels in a dose-dependent manner, probably pointing out the link between passive smoking and cardiovascular events.<xref ref-type="bibr" rid="ref50">50</xref> It was also shown that male gender was independently associated with elevated homocysteine levels.<xref ref-type="bibr" rid="ref51">51</xref> Aging was also demonstrated to be accompanied by elevated homocysteine.<xref ref-type="bibr" rid="ref52">52</xref> Having two risk factors about hyperhomocysteinemia, such as male gender and smoking we awaited to find higher levels of homocysteine in our smoking male subjects, but we could not find any statistically significant difference between the groups. Homocysteine levels of our smoking group was nonsignificantly high. Perhaps if we had formed a larger group, we would have find a satisfying result. We may also explain our results by the apparently low age of our subjects.</p><p>In discordance with previous data on the relation of resistin with inflammatory markers such as CRP.<xref ref-type="bibr" rid="ref44">44</xref>&#x02013;<xref ref-type="bibr" rid="ref47">47</xref> we failed to observe any correlation between CRP, homocysteine, uric acid and resistin. We can explain the difference in our results by a number of conditions. Primarily, our groups comprised apparently healthy men. Second, our subjects were young having the mean age of 36.8&#x000b1;6.8 in smokers and 36.7&#x000b1; 7.2 in non-smokers. Third, we measured each marker at study enrtry and thus could not evaluate the effects of changes in the levels of these markers over time. The discrepancy of previous results with ours may be related to the time of the measurement of the markers. We think that variation over time in levels of these markers may change the correlations.</p><p>In conclusion, we want to speculate that smoking may have influence on resistin levels and in smokers insulin resistance is related to resistin levels. Furthermore, we suggest that in smoker and non-smokers, body mass may not have any association with resistin. Our results also makes us think that this small group of atherosclerotic markers are not associated to resistin levels when the subjects smoke or not. Larger and longer studies with subjects having greater range of age and two sexes may enlighten the idea of the association of CRP, homocysteine and uric acid with resistin either in smokers or non-smokers.</p></sec><sec id="sec1-4"><title>Authors&#x02019; Contributions</title><p>Design: fG&#x000fc;l G&#x000fc;rsoy, Onur E&#x0015f;bah</p><p>Analysis and interpretation of the data: G&#x000fc;l G&#x000fc;rsoy, Onur E&#x0015f;bah, Berrin Demirba&#x0015f;.</p><p>Final approval of the article: G&#x000fc;l G&#x000fc;rsoy, Onur E&#x0015f;bah, Nazl&#x00131; G&#x000fc;lsoy K&#x00131;rnap, Hacer &#x000c7;etiner, Berrin Demirba&#x0015f;, Ya&#x0015f;ar Acar, Murat Bayram.</p><p>Statistical expertise: Onur E&#x0015f;bah, Ya&#x0015f;ar Acar.</p><p>Collection of data: Onur E&#x0015f;bah, Murat Bayram, Nazl&#x00131; G&#x000fc;lsoy K&#x00131;rnap, Hacer &#x000c7;etiner.</p></sec></body><back><ack><p>We thank the patients.</p></ack><fn-group><fn fn-type="conflict"><p><bold>Conflict of Interests</bold> Authors have no conflict of interests.</p></fn></fn-group><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luomala</surname><given-names>M</given-names></name><name><surname>Paiva</surname><given-names>H</given-names></name><name><surname>Thelen</surname><given-names>K</given-names></name><name><surname>Laaksonen</surname><given-names>R</given-names></name><name><surname>Saarela</surname><given-names>M</given-names></name><name><surname>Mattila</surname><given-names>K</given-names></name><etal/></person-group><article-title>Osteopontin levels are associated with cholesterol synthesis markers in mildly hypercholesterolaemic patients</article-title><source>Acta Cardiol</source><year>2007</year><volume>62</volume><issue>2</issue><fpage>177</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">17536607</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pepys</surname><given-names>MB</given-names></name><name><surname>Hirschfield</surname><given-names>GM</given-names></name></person-group><article-title>C-reactive protein: a critical update</article-title><source>J Clin Invest</source><year>2003</year><volume>111</volume><issue>12</issue><fpage>1805</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">12813013</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scirica</surname><given-names>BM</given-names></name><name><surname>Morrow</surname><given-names>DA</given-names></name></person-group><article-title>Is C-reactive protein an innocent bystander or proatherogenic culprit. The verdict is still out?</article-title><source>Circulation</source><year>2006</year><volume>113</volume><issue>17</issue><fpage>2128</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">16651484</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hingorani</surname><given-names>AD</given-names></name><name><surname>Shah</surname><given-names>T</given-names></name><name><surname>Casas</surname><given-names>JP</given-names></name></person-group><article-title>Linking observational and genetic approaches to determine the role of C-reactive protein in heart disease risk</article-title><source>Eur Heart J</source><year>2006</year><volume>27</volume><issue>11</issue><fpage>1261</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">16684780</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>M</given-names></name><name><surname>Zhan</surname><given-names>M</given-names></name><name><surname>Havas</surname><given-names>S</given-names></name></person-group><article-title>High attributable risk of elevated Linking observational and genetic approaches to determine the role of C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey</article-title><source>Arch Intern Med</source><year>2005</year><volume>165</volume><issue>18</issue><fpage>2063</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16216995</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buckley</surname><given-names>DI</given-names></name><name><surname>Fu</surname><given-names>R</given-names></name><name><surname>Freeman</surname><given-names>M</given-names></name><name><surname>Rogers</surname><given-names>K</given-names></name><name><surname>Helfand</surname><given-names>M</given-names></name></person-group><article-title>C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force</article-title><source>Ann Intern Med</source><year>2009</year><volume>151</volume><issue>7</issue><fpage>483</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">19805771</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarkun</surname><given-names>I</given-names></name><name><surname>Cetinarslan</surname><given-names>B</given-names></name><name><surname>Canturk</surname><given-names>Z</given-names></name></person-group><article-title>Lipoprotein(a) concentrations in patients with type 2 diabetes mellitus without cardiovascular disease: relationship to metabolic parameters and diabetic complications</article-title><source>Nutr Metab Cardiovasc Dis</source><year>2002</year><volume>12</volume><issue>3</issue><fpage>127</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">12325469</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oudi</surname><given-names>ME</given-names></name><name><surname>Aouni</surname><given-names>Z</given-names></name><name><surname>Mazigh</surname><given-names>C</given-names></name><name><surname>Khochkar</surname><given-names>R</given-names></name><name><surname>Gazoueni</surname><given-names>E</given-names></name><name><surname>Haouela</surname><given-names>H</given-names></name><etal/></person-group><article-title>Homocysteine and markers of inflammation in acute coronary syndrome</article-title><source>Exp Clin Cardiol</source><year>2010</year><volume>15</volume><issue>2</issue><fpage>e25</fpage><lpage>e28</lpage><pub-id pub-id-type="pmid">20631860</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>YQ</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>YX</given-names></name><name><surname>Wang</surname><given-names>YL</given-names></name><name><surname>Luo</surname><given-names>YY</given-names></name><name><surname>Hu</surname><given-names>DY</given-names></name><etal/></person-group><article-title>Predictive value of serum uric acid on cardiovascular disease and all-cause mortality in urban Chinese patients</article-title><source>Chin Med J (Engl)</source><year>2010</year><volume>123</volume><issue>11</issue><fpage>1387</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">20819592</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnan</surname><given-names>E</given-names></name><name><surname>Sokolove</surname><given-names>J</given-names></name></person-group><article-title>Uric acid in heart disease: a new C-reactive protein?</article-title><source>Curr Opin Rheumatol</source><year>2011</year><volume>23</volume><issue>2</issue><fpage>174</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">21178630</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues</surname><given-names>TC</given-names></name><name><surname>Maahs</surname><given-names>DM</given-names></name><name><surname>Johnson</surname><given-names>RJ</given-names></name><name><surname>Jalal</surname><given-names>DI</given-names></name><name><surname>Kinney</surname><given-names>GL</given-names></name><name><surname>Rivard</surname><given-names>C</given-names></name><etal/></person-group><article-title>Serum uric acid predicts progression of subclinical coronary atherosclerosis in individuals without renal disease</article-title><source>Diabetes Care</source><year>2010</year><volume>33</volume><issue>11</issue><fpage>2471</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">20798338</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willi</surname><given-names>C</given-names></name><name><surname>Bodenmann</surname><given-names>P</given-names></name><name><surname>Ghali</surname><given-names>WA</given-names></name><name><surname>Faris</surname><given-names>PD</given-names></name><name><surname>Cornuz</surname><given-names>J</given-names></name></person-group><article-title>Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis</article-title><source>JAMA</source><year>2007</year><volume>298</volume><issue>22</issue><fpage>2654</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">18073361</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ronnemaa</surname><given-names>T</given-names></name><name><surname>Ronnemaa</surname><given-names>EM</given-names></name><name><surname>Puukka</surname><given-names>P</given-names></name><name><surname>Pyorala</surname><given-names>K</given-names></name><name><surname>Laakso</surname><given-names>M</given-names></name></person-group><article-title>Smoking is independently associated with high plasma insulin levels in nondiabetic men</article-title><source>Diabetes Care</source><year>1996</year><volume>19</volume><issue>11</issue><fpage>1229</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">8908385</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakashita</surname><given-names>Y</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name><name><surname>Kitamura</surname><given-names>A</given-names></name><name><surname>Kiyama</surname><given-names>M</given-names></name><name><surname>Ishikawa</surname><given-names>Y</given-names></name><name><surname>Mikami</surname><given-names>H</given-names></name></person-group><article-title>Relationships of cigarette smoking and alcohol consumption to metabolic syndrome in Japanese men</article-title><source>J Epidemiol</source><year>2010</year><volume>20</volume><issue>5</issue><fpage>391</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">20699598</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al Mutairi</surname><given-names>SS</given-names></name><name><surname>Mojiminiyi</surname><given-names>OA</given-names></name><name><surname>Shihab-Eldeen</surname><given-names>AA</given-names></name><name><surname>Al</surname><given-names>SA</given-names></name><name><surname>Abdella</surname><given-names>N</given-names></name></person-group><article-title>Effect of smoking habit on circulating adipokines in diabetic and non-diabetic subjects</article-title><source>Ann Nutr Metab</source><year>2008</year><volume>52</volume><issue>4</issue><fpage>329</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">18714151</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Daghri</surname><given-names>NM</given-names></name><name><surname>Al-Attas</surname><given-names>OS</given-names></name><name><surname>Hussain</surname><given-names>T</given-names></name><name><surname>Sabico</surname><given-names>S</given-names></name><name><surname>Bamakhramah</surname><given-names>A</given-names></name></person-group><article-title>Altered levels of adipocytokines in type 2 diabetic cigarette smokers</article-title><source>Diabetes Res Clin Pract</source><year>2009</year><volume>83</volume><issue>2</issue><fpage>e37</fpage><lpage>e39</lpage><pub-id pub-id-type="pmid">19111930</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stofkova</surname><given-names>A</given-names></name></person-group><article-title>Resistin and visfatin: regulators of insulin sensitivity, inflammation and immunity</article-title><source>Endocr Regul</source><year>2010</year><volume>44</volume><issue>1</issue><fpage>25</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">20151765</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gursoy</surname><given-names>G</given-names></name><name><surname>Kyrnap</surname><given-names>NG</given-names></name><name><surname>Esbah</surname><given-names>O</given-names></name><name><surname>Acar</surname><given-names>Y</given-names></name><name><surname>Demirbas</surname><given-names>B</given-names></name><name><surname>Akcayoz</surname><given-names>S</given-names></name></person-group><article-title>The relationship between plasma omentin-1 levels and insulin resistance in newly diagnosed type 2 diabetic women</article-title><source>Clin Rev Opin</source><year>2010</year><volume>2</volume><issue>4</issue><fpage>49</fpage><lpage>54</lpage></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gursoy</surname><given-names>G</given-names></name><name><surname>Alagoz</surname><given-names>S</given-names></name><name><surname>Acar</surname><given-names>Y</given-names></name><name><surname>Demirbas</surname><given-names>B</given-names></name><name><surname>Cetiner</surname><given-names>H</given-names></name><name><surname>Kilic</surname><given-names>Z</given-names></name></person-group><article-title>Osteopontin a new probable marker for atherosclerosis in obese women</article-title><source>Clin Rev Opin</source><year>2010</year><volume>2</volume><issue>3</issue><fpage>35</fpage><lpage>40</lpage></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gursoy</surname><given-names>G</given-names></name><name><surname>Akcayoz</surname><given-names>SS</given-names></name><name><surname>Acar</surname><given-names>Y</given-names></name><name><surname>Demirbas</surname><given-names>B</given-names></name></person-group><article-title>Visfatin in hyperlipidemic female patients</article-title><source>J Medicine Medical Sciences</source><year>2010</year><volume>1</volume><issue>4</issue><fpage>120</fpage><lpage>5</lpage></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steppan</surname><given-names>CM</given-names></name><name><surname>Bailey</surname><given-names>ST</given-names></name><name><surname>Bhat</surname><given-names>S</given-names></name><name><surname>Brown</surname><given-names>EJ</given-names></name><name><surname>Banerjee</surname><given-names>RR</given-names></name><name><surname>Wright</surname><given-names>CM</given-names></name><etal/></person-group><article-title>The hormone resistin links obesity to diabetes</article-title><source>Nature</source><year>2001</year><volume>409</volume><issue>6818</issue><fpage>307</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">11201732</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>KH</given-names></name><name><surname>Lee</surname><given-names>K</given-names></name><name><surname>Moon</surname><given-names>YS</given-names></name><name><surname>Sul</surname><given-names>HS</given-names></name></person-group><article-title>A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><issue>14</issue><fpage>11252</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">11278254</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holcomb</surname><given-names>IN</given-names></name><name><surname>Kabakoff</surname><given-names>RC</given-names></name><name><surname>Chan</surname><given-names>B</given-names></name><name><surname>Baker</surname><given-names>TW</given-names></name><name><surname>Gurney</surname><given-names>A</given-names></name><name><surname>Henzel</surname><given-names>W</given-names></name><etal/></person-group><article-title>FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family</article-title><source>EMBO J</source><year>2000</year><volume>19</volume><issue>15</issue><fpage>4046</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">10921885</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Harithy</surname><given-names>RN</given-names></name><name><surname>Al-Ghamdi</surname><given-names>S</given-names></name></person-group><article-title>Serum resistin, adiposity and insulin resistance in Saudi women with type 2 diabetes mellitus</article-title><source>Ann Saudi Med</source><year>2005</year><volume>25</volume><issue>4</issue><fpage>283</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">16212119</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savage</surname><given-names>DB</given-names></name><name><surname>Sewter</surname><given-names>CP</given-names></name><name><surname>Klenk</surname><given-names>ES</given-names></name><name><surname>Segal</surname><given-names>DG</given-names></name><name><surname>Vidal-Puig</surname><given-names>A</given-names></name><name><surname>Considine</surname><given-names>RV</given-names></name><etal/></person-group><article-title>Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans</article-title><source>Diabetes</source><year>2001</year><volume>50</volume><issue>10</issue><fpage>2199</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">11574398</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Chan</surname><given-names>JL</given-names></name><name><surname>Yiannakouris</surname><given-names>N</given-names></name><name><surname>Kontogianni</surname><given-names>M</given-names></name><name><surname>Estrada</surname><given-names>E</given-names></name><name><surname>Seip</surname><given-names>R</given-names></name><etal/></person-group><article-title>Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects</article-title><source>J Clin Endocrinol Metab</source><year>2003</year><volume>88</volume><issue>10</issue><fpage>4848</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">14557464</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vozarova de</surname><given-names>Court</given-names></name><name><surname>Degawa-Yamauchi</surname><given-names>M</given-names></name><name><surname>Considine</surname><given-names>RV</given-names></name><name><surname>Tataranni</surname><given-names>PA</given-names></name></person-group><article-title>High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians</article-title><source>Diabetes</source><year>2004</year><volume>53</volume><issue>5</issue><fpage>1279</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">15111497</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rea</surname><given-names>R</given-names></name><name><surname>Donnelly</surname><given-names>R</given-names></name></person-group><article-title>Resistin: an adipocyte-derived hormone. Has it a role in diabetes and obesity?</article-title><source>Diabetes Obes Metab</source><year>2004</year><volume>6</volume><issue>3</issue><fpage>163</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">15056123</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Utzschneider</surname><given-names>KM</given-names></name><name><surname>Carr</surname><given-names>DB</given-names></name><name><surname>Tong</surname><given-names>J</given-names></name><name><surname>Wallace</surname><given-names>TM</given-names></name><name><surname>Hull</surname><given-names>RL</given-names></name><name><surname>Zraika</surname><given-names>S</given-names></name><etal/></person-group><article-title>Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans</article-title><source>Diabetologia</source><year>2005</year><volume>48</volume><issue>11</issue><fpage>2330</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">16143861</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makimura</surname><given-names>H</given-names></name><name><surname>Mizuno</surname><given-names>TM</given-names></name><name><surname>Bergen</surname><given-names>H</given-names></name><name><surname>Mobbs</surname><given-names>CV</given-names></name></person-group><article-title>Adiponectin is stimulated by adrenalectomy in ob/ob mice and is highly correlated with resistin mRNA</article-title><source>Am J Physiol Endocrinol Metab</source><year>2002</year><volume>283</volume><issue>6</issue><fpage>E1266</fpage><lpage>E1271</lpage><pub-id pub-id-type="pmid">12388167</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>TM</given-names></name><name><surname>Levy</surname><given-names>JC</given-names></name><name><surname>Matthews</surname><given-names>DR</given-names></name></person-group><article-title>Use and abuse of HOMA modeling</article-title><source>Diabetes Care</source><year>2004</year><volume>27</volume><issue>6</issue><fpage>1487</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">15161807</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>PW</given-names></name><name><surname>D&#x02019;Agostino</surname><given-names>RB</given-names></name><name><surname>Levy</surname><given-names>D</given-names></name><name><surname>Belanger</surname><given-names>AM</given-names></name><name><surname>Silbershatz</surname><given-names>H</given-names></name><name><surname>Kannel</surname><given-names>WB</given-names></name></person-group><article-title>Prediction of coronary heart disease using risk factor categories</article-title><source>Circulation</source><year>1998</year><volume>97</volume><issue>18</issue><fpage>1837</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">9603539</pub-id></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenland</surname><given-names>P</given-names></name><name><surname>Knoll</surname><given-names>MD</given-names></name><name><surname>Stamler</surname><given-names>J</given-names></name><name><surname>Neaton</surname><given-names>JD</given-names></name><name><surname>Dyer</surname><given-names>AR</given-names></name><name><surname>Garside</surname><given-names>DB</given-names></name><etal/></person-group><article-title>Major risk factors as antecedents of fatal and nonfatal coronary heart disease events</article-title><source>JAMA</source><year>2003</year><volume>290</volume><issue>7</issue><fpage>891</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">12928465</pub-id></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ridker</surname><given-names>PM</given-names></name><name><surname>Cushman</surname><given-names>M</given-names></name><name><surname>Stampfer</surname><given-names>MJ</given-names></name><name><surname>Tracy</surname><given-names>RP</given-names></name><name><surname>Hennekens</surname><given-names>CH</given-names></name></person-group><article-title>Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men</article-title><source>N Engl J Med</source><year>1997</year><volume>336</volume><issue>14</issue><fpage>973</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9077376</pub-id></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ridker</surname><given-names>PM</given-names></name><name><surname>Rifai</surname><given-names>N</given-names></name><name><surname>Rose</surname><given-names>L</given-names></name><name><surname>Buring</surname><given-names>JE</given-names></name><name><surname>Cook</surname><given-names>NR</given-names></name></person-group><article-title>Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events</article-title><source>N Engl J Med</source><year>2002</year><volume>347</volume><issue>20</issue><fpage>1557</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">12432042</pub-id></element-citation></ref><ref id="ref36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agoston-Coldea</surname><given-names>L</given-names></name><name><surname>Mocan</surname><given-names>T</given-names></name><name><surname>Seicean</surname><given-names>A</given-names></name><name><surname>Gatfosse</surname><given-names>M</given-names></name><name><surname>Rosenstingl</surname><given-names>S</given-names></name></person-group><article-title>The plasma homocysteine concentrations and prior myocardial infarction</article-title><source>Rom J Intern Med</source><year>2010</year><volume>48</volume><issue>1</issue><fpage>65</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">21180243</pub-id></element-citation></ref><ref id="ref37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname><given-names>R</given-names></name><name><surname>Halsey</surname><given-names>J</given-names></name><name><surname>Bennett</surname><given-names>D</given-names></name><name><surname>Lewington</surname><given-names>S</given-names></name></person-group><article-title>Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials</article-title><source>J Inherit Metab Dis</source><year>2011</year><volume>34</volume><issue>1</issue><fpage>83</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">21069462</pub-id></element-citation></ref><ref id="ref38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nam</surname><given-names>GE</given-names></name><name><surname>Lee</surname><given-names>KS</given-names></name><name><surname>Park</surname><given-names>YG</given-names></name><name><surname>Cho</surname><given-names>KH</given-names></name><name><surname>Lee</surname><given-names>SH</given-names></name><name><surname>Ko</surname><given-names>BJ</given-names></name><etal/></person-group><article-title>An increase in serum uric acid concentrations is associated with an increase in the Framingham risk score in Korean adults</article-title><source>Clin Chem Lab Med</source><year>2011</year><volume>49</volume><issue>5</issue><fpage>909</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">21288174</pub-id></element-citation></ref><ref id="ref39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>Z</given-names></name><name><surname>Dai</surname><given-names>T</given-names></name><name><surname>Zhong</surname><given-names>X</given-names></name><name><surname>Tian</surname><given-names>Y</given-names></name><name><surname>Leppo</surname><given-names>MK</given-names></name><name><surname>Gao</surname><given-names>WD</given-names></name></person-group><article-title>Preservation of cardiac contractility after long-term therapy with oxypurinol in post-ischemic heart failure in mice</article-title><source>Eur J Pharmacol</source><year>2009</year><volume>621</volume><issue>1-3</issue><fpage>71</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">19737552</pub-id></element-citation></ref><ref id="ref40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Targher</surname><given-names>G</given-names></name><name><surname>Alberiche</surname><given-names>M</given-names></name><name><surname>Zenere</surname><given-names>MB</given-names></name><name><surname>Bonadonna</surname><given-names>RC</given-names></name><name><surname>Muggeo</surname><given-names>M</given-names></name><name><surname>Bonora</surname><given-names>E</given-names></name></person-group><article-title>Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus</article-title><source>J Clin Endocrinol Metab</source><year>1997</year><volume>82</volume><issue>11</issue><fpage>3619</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">9360516</pub-id></element-citation></ref><ref id="ref41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al Mutairi</surname><given-names>SS</given-names></name><name><surname>Mojiminiyi</surname><given-names>OA</given-names></name><name><surname>Shihab-Eldeen</surname><given-names>AA</given-names></name><name><surname>Al</surname><given-names>SA</given-names></name><name><surname>Abdella</surname><given-names>N</given-names></name></person-group><article-title>Effect of smoking habit on circulating adipokines in diabetic and non-diabetic subjects</article-title><source>Ann Nutr Metab</source><year>2008</year><volume>52</volume><issue>4</issue><fpage>329</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">18714151</pub-id></element-citation></ref><ref id="ref42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Efstathiou</surname><given-names>SP</given-names></name><name><surname>Skeva</surname><given-names>II</given-names></name><name><surname>Dimas</surname><given-names>C</given-names></name><name><surname>Panagiotou</surname><given-names>A</given-names></name><name><surname>Parisi</surname><given-names>K</given-names></name><name><surname>Tzanoumis</surname><given-names>L</given-names></name><etal/></person-group><article-title>Smoking cessation increases serum adiponectin levels in an apparently healthy Greek population</article-title><source>Atherosclerosis</source><year>2009</year><volume>205</volume><issue>2</issue><fpage>632</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">19217624</pub-id></element-citation></ref><ref id="ref43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez-Ambrosi</surname><given-names>J</given-names></name><name><surname>Fruhbeck</surname><given-names>G</given-names></name></person-group><article-title>Evidence for the involvement of resistin in inflammation and cardiovascular disease</article-title><source>Curr Diabetes Rev</source><year>2005</year><volume>1</volume><issue>3</issue><fpage>227</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">18220599</pub-id></element-citation></ref><ref id="ref44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Luis</surname><given-names>DA</given-names></name><name><surname>Sagrado</surname><given-names>MG</given-names></name><name><surname>Conde</surname><given-names>R</given-names></name><name><surname>Aller</surname><given-names>R</given-names></name><name><surname>Izaola</surname><given-names>O</given-names></name><name><surname>de la Fuente</surname><given-names>B</given-names></name><etal/></person-group><article-title>Relation of resistin levels with cardiovascular risk factors, insulin resistance and inflammation in naive diabetes obese patients</article-title><source>Diabetes Res Clin Pract</source><year>2010</year><volume>89</volume><issue>2</issue><fpage>110</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">20413173</pub-id></element-citation></ref><ref id="ref45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Straburzynska-Lupa</surname><given-names>A</given-names></name><name><surname>Nowak</surname><given-names>A</given-names></name><name><surname>Pilaczynska-Szczesniak</surname><given-names>L</given-names></name><name><surname>Straburzynska-Migaj</surname><given-names>E</given-names></name><name><surname>Romanowski</surname><given-names>W</given-names></name><name><surname>Karolkiewicz</surname><given-names>J</given-names></name><etal/></person-group><article-title>Visfatin, resistin, hsCRP and insulin resistance in relation to abdominal obesity in women with rheumatoid arthritis</article-title><source>Clin Exp Rheumatol</source><year>2010</year><volume>28</volume><issue>1</issue><fpage>19</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">20346233</pub-id></element-citation></ref><ref id="ref46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kopff</surname><given-names>B</given-names></name><name><surname>Jegier</surname><given-names>A</given-names></name></person-group><article-title>Adipokines: adiponectin, leptin, resistin and coronary heart disease risk</article-title><source>Przegl Lek</source><year>2005</year><volume>62</volume><issue>Suppl 3</issue><fpage>69</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">16521924</pub-id></element-citation></ref><ref id="ref47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>BH</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Ding</surname><given-names>EL</given-names></name><name><surname>Roberts</surname><given-names>CK</given-names></name><name><surname>Manson</surname><given-names>JE</given-names></name><name><surname>Rifai</surname><given-names>N</given-names></name><etal/></person-group><article-title>Circulating levels of resistin and risk of type 2 diabetes in men and women: results from two prospective cohorts</article-title><source>Diabetes Care</source><year>2009</year><volume>32</volume><issue>2</issue><fpage>329</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">18957529</pub-id></element-citation></ref><ref id="ref48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>JM</given-names></name><name><surname>Chai</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Lin</surname><given-names>PH</given-names></name><etal/></person-group><article-title>Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2010</year><volume>299</volume><issue>1</issue><fpage>H193</fpage><lpage>H201</lpage><pub-id pub-id-type="pmid">20435848</pub-id></element-citation></ref><ref id="ref49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norata</surname><given-names>GD</given-names></name><name><surname>Ongari</surname><given-names>M</given-names></name><name><surname>Garlaschelli</surname><given-names>K</given-names></name><name><surname>Raselli</surname><given-names>S</given-names></name><name><surname>Grigore</surname><given-names>L</given-names></name><name><surname>Catapano</surname><given-names>AL</given-names></name></person-group><article-title>Plasma resistin levels correlate with determinants of the metabolic syndrome</article-title><source>Eur J Endocrinol</source><year>2007</year><volume>156</volume><issue>2</issue><fpage>279</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">17287419</pub-id></element-citation></ref><ref id="ref50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>DB</given-names></name><name><surname>Oh</surname><given-names>YS</given-names></name><name><surname>Yoo</surname><given-names>KD</given-names></name><name><surname>Lee</surname><given-names>JM</given-names></name><name><surname>Park</surname><given-names>CS</given-names></name><name><surname>Ihm</surname><given-names>SH</given-names></name><etal/></person-group><article-title>Passive smoking in never-smokers is associated with increased plasma homocysteine levels</article-title><source>Int Heart J</source><year>2010</year><volume>51</volume><issue>3</issue><fpage>183</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">20558908</pub-id></element-citation></ref><ref id="ref51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selhub</surname><given-names>J</given-names></name></person-group><article-title>Homocysteine metabolism</article-title><source>Annu Rev Nutr</source><year>1999</year><volume>19</volume><fpage>217</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">10448523</pub-id></element-citation></ref><ref id="ref52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dominguez</surname><given-names>LJ</given-names></name><name><surname>Galioto</surname><given-names>A</given-names></name><name><surname>Pineo</surname><given-names>A</given-names></name><name><surname>Ferlisi</surname><given-names>A</given-names></name><name><surname>Ciaccio</surname><given-names>M</given-names></name><name><surname>Putignano</surname><given-names>E</given-names></name><etal/></person-group><article-title>Age, homocysteine, and oxidative stress: relation to hypertension and type 2 diabetes mellitus</article-title><source>J Am Coll Nutr</source><year>2010</year><volume>29</volume><issue>1</issue><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">20595639</pub-id></element-citation></ref></ref-list></back></article>